Skip to main content
Premium Trial:

Request an Annual Quote

Dante Labs Acquires Cambridge Cancer Genomics

NEW YORK — Dante Labs said on Wednesday that it has acquired UK-based cancer informatics firm Cambridge Cancer Genomics, or CCG, for an undisclosed amount.

Additional terms of the deal were not disclosed.

According to New York City-based Dante Labs, the acquisition will bring together its CE-IVD-marked Immensa Genomics Interpretation Software, which enables the interpretation of whole-genome sequencing data in a clinical setting, with CCG's artificial intelligence-based OncOS precision oncology software.

About a year ago, Dante Labs and CCG began working together with Nonacus to build a high-throughput cancer sequencing and interpretation service for tumor profiling.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.